JET2019

講演情報

Presentation Awards

[L2-3] Presentation Awards
Heat-6 Clinical trials-3

2019年2月22日(金) 13:40 〜 15:10 HallL-2 (Nexus)

Moderator: Yuji Ikari(Tokai University),Jimmy Wei-Hwa,Tan(Tainan Municipal An-Nan Hospital, China Medical University, Taiwan)
Panelist: Eiji Ojima(Mito Kyodo General Hospital, Tsukuba University Hospital Mito Clinical Education and Training Center),Yoshinori Shimooka(Megumino hospital)

[MO-39] Presentation Awards

The impact of gender on 30-day and 5-year outcomes post elective endovascular repair of abdominal aortic aneurysm.

Joseph Faraj

Objective: Several studies report worse outcomes in women compared with men after endovascular aneurysm repair (EVAR). This study aimed to evaluate gender-specific early and 5-year outcomes after EVAR.

Methods: A total of 409 consecutive patients underwent elective EVAR from 2004 to 2017 at two hospitals in Western Australia. Baseline, intraoperative, and postoperative variables were examined retrospectively according to gender.

Results: Of the 409 patients 57 (14%) were women and 352 (86%) men. Females were older (median age, 76.8 vs 73.5 years; p = 0.017). Men were more likely to be past smokers (40.9% vs. 22.8%, p = 0.005), have a history of CABG (11.2% vs. 3.5%, p = 0.042) and malignancy (23.9% vs.10.7%) than women. No difference in 30-day mortality or composite end-points was demonstrated for women compared with men (3.5% vs. 0.3%; p = 0.052 and 31.6% vs. 27.8%; p = 0.562 respectively). The Kaplan- Meier curves demonstrated similar outcomes for long-term survival amongst men and women (p = 0.928). Survival analyses adjusting for covariates demonstrated a nonsignificant difference in long-term mortality, composite end-points and reintervention rate between genders.

Conclusions: Women undergoing EVAR have comparable outcomes to men, implying that EVAR remains the treatment of choice for female patients.